🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Arm 1 cemiplimab

Found 48 matching trials

A Trial to Learn How the Cancer Vaccine BNT116 in Combination With Cemiplimab Works and How Safe the Combination is in Adults With Advanced Non-small Cell Lung Cancer (EMPOWERVAX Lung 1)

PHASE2

This study is researching an investigational drug, called BNT116, in combin...

Status

Active Not Recruiting

Location

The Oncology Institute of Hope and Innovation

Start Date

2023-04-21

Trial ID

NCT05557591

Treatments Being Tested

BNT116 Cemiplimab

A Clinical Study to Assess the Efficacy of Adjuvant Immunotherapy With Cemiplimab in Patients With Surgically Removed Non-small Cell Lung Cancer Who Have Not Received Prior Chemotherapy

PHASE3

ARCH is a randomised, stratified, multicentre, phase III trial. Protocol tr...

Status

Recruiting

Location

Wien AKH

Start Date

2026-01-12

Trial ID

NCT06931717

Treatments Being Tested

Cemiplimab

A Study of Recombinant Vaccinia Virus in Combination With Cemiplimab for Renal Cell Carcinoma

PHASE1

This is a Phase 1b/2a, open-label, multi-center, dose-escalation and safety...

Status

Completed

Location

Site 2644 University of California, Irvine

Start Date

2018-06-19

Trial ID

NCT03294083

Treatments Being Tested

Pexastimogene Devacirepvec (Pexa-Vec)Cemiplimab

Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients

PHASE2

This is a Phase 2 study designed to determine the preliminary anti-tumor ac...

Status

Active Not Recruiting

Location

Saint John's Health Center - John Wayne Cancer Institute (JWCI)

Start Date

2020-04-24

Trial ID

NCT04291105

Treatments Being Tested

VV1 Cemiplimab

Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer

PHASE2

This phase II trial compares the effect of giving cabozantinib with or with...

Status

Recruiting

Location

Mayo Clinic Hospital in Arizona

Start Date

2026-02-22

Trial ID

NCT06900595

Treatments Being Tested

Biospecimen Collection Cabozantinib Cemiplimab Computed Tomography Magnetic Resonance Imaging

Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer

PHASE2

This phase II trial tests the addition of chemotherapy, with carboplatin an...

Status

Recruiting

Location

Banner University Medical Center - Tucson

Start Date

2026-04-24

Trial ID

NCT07195734

Treatments Being Tested

Biospecimen Collection Carboplatin Cemiplimab Cisplatin Computed Tomography Paclitaxel Positron Emission Tomography Radiation Therapy Salvage Surgery

Neoadjuvant Merkel Cell Carcinoma Therapy (Tx) With the PD-1 Inhibitor Cemiplimab

PHASE2

The study is a randomized, double blind, placebo-controlled, non-comparativ...

Status

Recruiting

Location

Nationales Centrum für Tumorerkrankungen

Start Date

2026-05-29

Trial ID

NCT07387198

Treatments Being Tested

Cemiplimab 350 mg i.v. on day 1 of every 21 days cycle for 2 cycles Placebo NaCl 0.9% solution i.v. on day 1 of every 21 days cycle for 2 cycles.

Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer

PHASE1

This phase I/II trial tests the safety and efficacy of split-course adaptiv...

Status

Recruiting

Location

Vanderbilt University/Ingram Cancer Center

Start Date

2023-05-09

Trial ID

NCT05501665

Treatments Being Tested

Biospecimen Collection Carboplatin Computed Tomography Fludeoxyglucose F-18 Nab-paclitaxel Pembrolizumab Pemetrexed Positron Emission Tomography Radiation Therapy [18-F] (fluoropropyl)-L-glutamate (FSPG) PET scan Ipilimumab Nivolumab Cemiplimab Atezolizumab

Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy

PHASE2

This pilot study is configured as a non-inferiority comparison of Performan...

Status

Recruiting

Location

Wake Forest Baptist Comprehensive Cancer Center

Start Date

2020-07-01

Trial ID

NCT04253964

Treatments Being Tested

Pembrolizumab Atezolizumab Cemiplimab-Rwlc Carboplatin Paclitaxel Nab paclitaxel Pemetrexed Cisplatin Quality of Life Questionnaire, lung cancer-specific (QLQ-LC13)QLQ-C30 Global Health/Quality of Life Questionnaire COPD Assessment Test and modified Medical Research Council Dyspnea Patient Reported Outcomes PROMIS and FACT-G Questionnaires Sleep Disorder Assessments (ISI, Berlin Sleep Questionnaire)

BIOmarker-guided Study to Evaluate the Efficacy and Safety of cemipLimab for advancEd Cutaneous T-cell Lymphoma

PHASE1

Background - Advanced cutaneous T-cell lymphoma (mycosis fungoides, MF) is ...

Status

Withdrawn

Location

Cross Cancer Institute

Start Date

2024-12

Trial ID

NCT05538988

Treatments Being Tested

Cemiplimab

Previous Next